The PPAR signaling pathway is essential for defending the liver against pathological assaults such as inflammation and cancer injuries [56], and KIAA1522's suppression of this pathway may increase the chance of unfavorable outcomes in HCC patients. Here, NHSL3 is linked to hepatocellular carcinoma.